Just - Evotec Biologics Receives Grant for AI-Driven Optimization of Monoclonal Antibody Developability for Affordable Access

Just - Evotec Biologics will optimize monoclonal antibodies ("mAbs") and other biologic modalitiesInvestment enables ten new J.MD™ projects encompassing molecular optimization including, but not limited to: improved titer, pharmacokinetics, …